Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients

Overview of attention for article published in Frontiers in oncology, August 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 24 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 22,607 followers.

RT @MetastasisWS: How can we improve clinical efficacy and outcome of drugs targeting #metastasis? At #MetastasisSummit Pralay Mukhopadhya…

15 Aug 2019

Reply Repost Favourite

RT @MetastasisWS: How can we improve clinical efficacy and outcome of drugs targeting #metastasis? At #MetastasisSummit Pralay Mukhopadhya…

14 Aug 2019

Reply Repost Favourite

How can we improve clinical efficacy and outcome of drugs targeting #metastasis? At #MetastasisSummit Pralay Mukhopadhyay will be exploring the underlying biological causes for lack of benefit to guide optimal treatment choices for patients. https://t.c

14 Aug 2019

Reply Repost Favourite

RT @FrontOncology: New research: Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients: Emerging de…

14 Aug 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.